alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Idiopathic Parkinson Disease in 10 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Kim, G | 1 |
Shin, N | 1 |
Kim, KS | 1 |
Tamura, H | 1 |
Sasaki, M | 1 |
Nakajima, S | 1 |
Nishio, R | 1 |
Saeki, N | 1 |
Katahira, M | 1 |
Tamano, H | 1 |
Takeda, A | 1 |
Pelosi, A | 1 |
Murray, TK | 1 |
Whalley, K | 1 |
Robinson, CS | 1 |
Ward, MA | 1 |
Hicks, CA | 1 |
Lodge, D | 1 |
Vandergriff, JL | 1 |
Baumbarger, P | 1 |
Siuda, E | 1 |
Gates, M | 1 |
Ogden, AM | 1 |
Skolnick, P | 1 |
Zimmerman, DM | 1 |
Nisenbaum, ES | 1 |
Bleakman, D | 1 |
O'Neill, MJ | 1 |
Galeffi, F | 1 |
Bianchi, L | 1 |
Bolam, JP | 1 |
Della Corte, L | 1 |
Calon, F | 1 |
Rajput, AH | 1 |
Hornykiewicz, O | 1 |
Bédard, PJ | 1 |
Di Paolo, T | 1 |
Ossowska, K | 1 |
Luquin, MR | 1 |
Obeso, JA | 1 |
Laguna, J | 1 |
Guillén, J | 1 |
Martínez-Lage, JM | 1 |
Klockgether, T | 1 |
Turski, L | 1 |
Svensson, TH | 1 |
Mathé, JM | 1 |
Nomikos, GG | 1 |
Schilström, B | 1 |
2 reviews available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Idiopathic Parkinson Disease
Article | Year |
---|---|
Cell-specific α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonism reveals new insights in the development of parkinson's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Glutamic Acid; Humans; Parkinson Disease | 2017 |
The role of excitatory amino acids in experimental models of Parkinson's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Catalepsy; Disease M | 1994 |
8 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Idiopathic Parkinson Disease
Article | Year |
---|---|
Galvanic vestibular stimulation down-regulated NMDA receptors in vestibular nucleus of PD model.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Electric Stimulation; Parkinson D | 2022 |
Reactive oxygen species produced by Zn
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dopaminergic Neurons; Edema; Hydr | 2023 |
LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Ac | 2003 |
The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis.
Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; | 2003 |
Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Topics: Aged; Aged, 80 and over; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Binding Sites; Bi | 2003 |
The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Ac | 1993 |
Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Basal Ganglia; Cycloleucine; Elec | 1993 |
Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anim | 1998 |